Ardizzone, A.; Bulzomì, M.; De Luca, F.; Silvestris, N.; Esposito, E.; Capra, A.P.
Dihydropyrimidine Dehydrogenase Polymorphism c.2194G>A Screening Is a Useful Tool for Decreasing Gastrointestinal and Hematological Adverse Drug Reaction Risk in Fluoropyrimidine-Treated Patients. Curr. Issues Mol. Biol. 2024, 46, 9831-9843.
https://doi.org/10.3390/cimb46090584
AMA Style
Ardizzone A, Bulzomì M, De Luca F, Silvestris N, Esposito E, Capra AP.
Dihydropyrimidine Dehydrogenase Polymorphism c.2194G>A Screening Is a Useful Tool for Decreasing Gastrointestinal and Hematological Adverse Drug Reaction Risk in Fluoropyrimidine-Treated Patients. Current Issues in Molecular Biology. 2024; 46(9):9831-9843.
https://doi.org/10.3390/cimb46090584
Chicago/Turabian Style
Ardizzone, Alessio, Maria Bulzomì, Fabiola De Luca, Nicola Silvestris, Emanuela Esposito, and Anna Paola Capra.
2024. "Dihydropyrimidine Dehydrogenase Polymorphism c.2194G>A Screening Is a Useful Tool for Decreasing Gastrointestinal and Hematological Adverse Drug Reaction Risk in Fluoropyrimidine-Treated Patients" Current Issues in Molecular Biology 46, no. 9: 9831-9843.
https://doi.org/10.3390/cimb46090584
APA Style
Ardizzone, A., Bulzomì, M., De Luca, F., Silvestris, N., Esposito, E., & Capra, A. P.
(2024). Dihydropyrimidine Dehydrogenase Polymorphism c.2194G>A Screening Is a Useful Tool for Decreasing Gastrointestinal and Hematological Adverse Drug Reaction Risk in Fluoropyrimidine-Treated Patients. Current Issues in Molecular Biology, 46(9), 9831-9843.
https://doi.org/10.3390/cimb46090584
_Kim.png)
